|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.200 USD | -12.31% |
|
+0.81% | +181.82% |
| Dec. 09 | Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants | RE |
| Dec. 08 | Immix Biopharma Prices $100 Million Offering | MT |
Share class: Immix Biopharma, Inc.
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 27,580,000 | 16,477,734 ( 59.75 %) | 72,363 ( 0.2624 %) | 59.75 % |
Major shareholders: Immix Biopharma, Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
14.47
%
| 4,858,913 | 14.47 % | 21 M $ |
9.652
%
| 3,241,076 | 9.652 % | 14 M $ |
3.4
%
| 1,141,683 | 3.4 % | 5 M $ |
3.113
%
| 1,045,221 | 3.113 % | 4 M $ |
2.737
%
| 918,880 | 2.737 % | 4 M $ |
Bleichroeder LP
2.531
%
| 850,000 | 2.531 % | 4 M $ |
2.211
%
| 742,414 | 2.211 % | 3 M $ |
Vanguard Fiduciary Trust Co.
2.175
%
| 730,162 | 2.175 % | 3 M $ |
Geode Capital Management LLC
0.5583
%
| 187,476 | 0.5583 % | 796 773 $ |
0.5204
%
| 174,754 | 0.5204 % | 742 705 $ |
░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
| Individuals | 36.37% |
| Institutional | 7.59% |
| Other | 0.72% |
| State Street Corp. | 0.29% |
| Unknown | 55.03% |
Based on 1000 largest holdings
Geographical origin of shareholders
Individuals
| 36.37% |
United States | 8.03% |
Canada | 0.25% |
United Kingdom | 0.16% |
Cayman Islands | 0.1% |
Japan | 0.05% |
Switzerland | 0.01% |
Based on 1000 largest holdings
Employees
20
- Stock Market
- Equities
- IMMX Stock
- Company Immix Biopharma, Inc.
- Share ownership
Select your edition
All financial news and data tailored to specific country editions
